Table 5. Univariable and Multivariable analysis for predictors of overall survival in propensity-score matched cohort.
| Characteristics | Univariable | Multivariable | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age >60 years | 1.52 (1.10–2.11) | 0.011 | 1.8 (1.28–2.53) | 0.001* | |
| Sex (male) | 0.82 (0.59–1.15) | 0.258 | – | – | |
| ALI score (low) | 1.55 (1.11–2.19) | 0.011 | 1.51 (1.08–2.13) | 0.017* | |
| T3/4 stage | 7.36 (3.88–13.99) | <0.001 | 3.53 (1.76–7.05) | <0.001* | |
| Lymph node metastasis (presence) | 3.57 (2.34–5.44) | <0.001 | 1.92 (1.22–3.02) | 0.005* | |
| Histological grade (poorly differentiated) | 1.87 (1.23–2.85) | 0.004 | 1.41 (0.91–2.18) | 0.124 | |
| Histological type (signet ring cell or mucinous adenocarcinoma) | 1.23 (0.82–1.83) | 0.312 | – | – | |
| Perineural invasion (presence) | 2.96 (2.13–4.13) | <0.001 | 1.77 (1.23–2.54) | 0.002* | |
| Vessel invasion (presence) | 2.39 (1.74–3.27) | <0.001 | 1.43 (1.02–1.99) | 0.036* | |
*, P value is statistically significant (P<0.05). ALI, advanced lung cancer inflammation index; HR, hazard ratio; CI, confidence interval.